Turn Therapeutics Inc. TTRX
Set alert
9.65 USD -0.78 -7.48%
At close · Nov 2
9.65 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
9.65 Day range 10.48
2.57 52-week range 16.45
- YTD
- +144.92%
- 1 year
- +98.97%
- Open
- 10.48
- Prev close
- 10.43
- Mkt cap
- 293.05M
- Vol
- 85.81K
- Avg vol
- 106.94K
- EPS
- -0.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.65
- High
- 10.48
1m chart
Built from the cached one-day intraday bars.
Signals (17)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:58 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:53 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:32 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:31 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:52 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:52 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:03 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:03 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:47 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:42 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:24 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:16 AM | 3 days ago |
Financials — quick view
TTRX Revenue — quarterly 0
TTRX Net income — quarterly -5.85M
TTRX EPS — quarterly -0.20
News
- This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
- This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
- WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10
- U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat
- This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24
- WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
- Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D.
Your note
Sign in to keep a note on TTRX — it syncs with the Stock Master app.